Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz‐Tretyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7235-7235
Open Access | Times Cited: 38
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer—Advances and Challenges
Attila A. Seyhan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13340-13340
Open Access | Times Cited: 30
Effectiveness of exercise-based interventions in preventing cancer therapy-related cardiac dysfunction in patients with breast cancer: A systematic review and network meta-analysis
Dandan Zhang, Xingyu Xiong, Hexiao Ding, et al.
International Journal of Nursing Studies (2025) Vol. 163, pp. 104997-104997
Closed Access | Times Cited: 1
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond
Umberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 6
Comprehensive review of non-invasive treatment related cardiovascular toxicity in breast cancer
C Li, Huijuan Dai, Xinning Guo, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 111759-111759
Closed Access
Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment
Carla Contaldi, Carmine D’Aniello, Domenico Panico, et al.
Life (2025) Vol. 15, Iss. 3, pp. 471-471
Open Access
Exosomes derived from microglia overexpressing miR-124-3p alleviate neuronal endoplasmic reticulum stress damage after repetitive mild traumatic brain injury
Yan Wang, Li Dai, Lan Zhang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 2010-2018
Open Access | Times Cited: 9
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3290-3290
Open Access | Times Cited: 8
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
Matthew G. Davey, Ray Abbas, Eoin Kerin, et al.
Breast Cancer Research and Treatment (2023) Vol. 202, Iss. 1, pp. 73-81
Open Access | Times Cited: 6
Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine
Younan Samuel, Aswin Babu, Foteini Karagkouni, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8337-8358
Open Access | Times Cited: 5
Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model
Michaela Adamcová, Helena Párová, Olga Lenčová-Popelová, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers
Isabel Moscoso, Moisés Rodríguez‐Mañero, María Cebro-Márquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11910-11910
Open Access | Times Cited: 1
Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
Raza Abbas Syed, Matthew G. Davey, Vinitha Richard, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12694-12694
Open Access | Times Cited: 3
Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients
Walter Schiffer, Lauren N. Pedersen, Matthew Lui, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 11, pp. 1589-1600
Open Access | Times Cited: 3
MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype
Muhammad Tariq, Vinitha Richard, Michael J. Kerin
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3007-3007
Open Access | Times Cited: 2
RNA biomarkers in cancer therapeutics: The promise of personalized oncology
Hector Katifelis, Maria Gazouli
Advances in clinical chemistry (2024), pp. 179-219
Closed Access
Exosome-Derived microRNAs in Hypertrophic Cardiomyopathy
Brian Wang
Cardiogenetics (2024) Vol. 14, Iss. 4, pp. 228-253
Open Access
CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity
Georgia S. Karanasiou, Lefteris Koumakis, Stelios Sfakianakis, et al.
2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) (2023), pp. 1-4
Closed Access
14,15-Dihydroxyeicosatrienoic acid, a soluble epoxide hydrolase metabolite in blood, is a predictor of anthracycline-induced cardiotoxicity – a hypothesis generating study
Júlia M. Santos, Aby Joiakim, David A. Putt, et al.
Cardio-Oncology (2023) Vol. 9, Iss. 1
Open Access
CARDIOCARE platform: A beyond the state of the art approach for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity*
Κostas Μ. Tsiouris, Georgia S. Karanasiou, Stelios Sfakianakis, et al.
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (2023), pp. 3907-3912
Closed Access
Page 1

Scroll to top